---
author: Harvey Guo
created: 2023-10-12 11:34
modified: 2023-10-12 11:34
aliases: Untitled
share: true
---
See also [[../Biochemistry/Lipid transport|Lipid transport]]
![[../../assets/img/Pasted image 20240208105331.png|Pasted image 20240208105331.png]]
# Statins
- Competitive inhibition of HMG-CoA reductase renders this enzyme unable to convert HMG-CoA to mevalonate (the rate-limiting step of cholesterol synthesis) → reduced intrahepatic cholesterol biosynthesis → <span style="background:rgba(240, 200, 0, 0.2)">upregulation of expression of LDL receptor gene via sterol regulatory element-binding protein (SREBP) → increased LDL recycling</span> and:
	- <span style="background:rgba(240, 200, 0, 0.2)">↓↓ LDL cholesterol</span>
	- ↑ HDL cholesterol
	- ↓ Triglyceride level
- Adverse effects
	- <span style="background:rgba(240, 200, 0, 0.2)">Statin-associated myopathy</span>
		- Muscle pain and weakness, <span style="background:rgba(240, 200, 0, 0.2)">especially when used alongside fibrates or niacin</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Myositis: ↑ CK</span> 
		- May progress to rhabdomyolysis: rare but severe side-effect that may lead to myoglobinuria → AKI (↑ BUN and ↑ creatinine)
		- Treatment must be discontinued if myopathy/rhabdomyolysis occurs.

![[../../assets/img/Pasted image 20231012113514.png|Pasted image 20231012113514.png]]
# Ezetimibe
- Mechanism of action: selective inhibition of cholesterol reabsorption at the<span style="background:rgba(240, 200, 0, 0.2)"> brush border of enterocytes (cholesterol transporter NPC1L1)</span> → ↓↓ LDL, little effect on HDL (slight ↑) and triglycerides (slight ↓)
- <span style="background:rgba(240, 200, 0, 0.2)">Adverse effects: ↑ Liver enzymes</span>
>[!Mnemonic] 
>Ezetim<span style="background:rgba(240, 200, 0, 0.2)">IB</span>e -- Intestinal brush border
# Fibrates
- Agents: bezafibrate, fenofibrate, and gemfibrozil
- Mechanism of action: <span style="background:rgba(240, 200, 0, 0.2)">activation of the peroxisome proliferator-activated receptor alpha (PPAR–α)</span> → ↑ lipoprotein lipase activity → <span style="background:rgba(240, 200, 0, 0.2)">more rapid degradation of LDL and triglycerides and induction of HDL synthesis</span> → ↓ LDL, ↑ HDL, <span style="background:rgba(240, 200, 0, 0.2)">↓↓↓ triglyceride</span>
- Adverse effects
	- Dyspepsia
	- <span style="background:rgba(240, 200, 0, 0.2)">Myopathy, especially in combination with statins</span> 
	- <span style="background:rgba(240, 200, 0, 0.2)">[[../GI/Cholelithiasis|Cholelithiasis]]: fibrates inhibit cholesterol 7α hydroxylase → decreased bile acid synthesis → supersaturation of bile with cholesterol (↑ cholesterol:bile acid ratio)</span>
	- ↑ LFTs (reversible)
 
![[../../assets/img/Pasted image 20231012134711.png|Pasted image 20231012134711.png]]
>[!tip] 
>Pioglitazone activates PPAR-γ. See [[../Endocrine/Diabetes mellitus#T2DM|Diabetes mellitus > T2DM]]
# [[../Biochemistry/Vitamin B3|Niacin]] (Vitamin B3)
- <span style="background:rgba(240, 200, 0, 0.2)">Mechanism of action: inhibits lipolysis and fatty acid release in adipose tissue through blockade of hormone-sensitive lipase and ↓ hepatic VLDL synthesis → ↓ triglyceride, ↓↓ LDL synthesis, ↑↑ HDL</span>![[../../assets/img/Pasted image 20231112162849.png|Pasted image 20231112162849.png]]
- Indication: high LDL cholesterol and lipoprotein(a) levels (> 50 mg/dL) despite statin and ezetimibe therapy (or if statins are contraindicated)
- Adverse effects
	- Flushing and pruritus: ↑ prostaglandin synthesis → peripheral vasodilation (pretreatment with aspirin or ibuprofen can minimize this side effect)
	- Hyperglycemia
	- <span style="background:rgba(240, 200, 0, 0.2)">[[../MSK/Gout|Hyperuricemia]] and [[../MSK/Gout|gout]]</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">[[../Biochemistry/Vitamin B3|Niacin]] decreases renal uric acid excretion.</span>
# Bile acid resins
- Drugs: cholestyramine, colestipol, colesevelam
- Mechanism of action
	- Ion exchange resin binds bile acids in the intestine  → interruption of enterohepatic circulation (<span style="background:rgba(240, 200, 0, 0.2)">↓ bile acid absorption and ↑ bile acid excretion</span>)  → ↑ conversion (compensatory) of cholesterol to bile → <span style="background:rgba(240, 200, 0, 0.2)">lowers cholesterol pool in the liver and promotes synthesis of LDL receptors and ↑ LDL receptor recycling</span> → <span style="background:rgba(240, 200, 0, 0.2)">↓↓ unbound LDL</span>, slightly ↑ HDL, and slightly <span style="background:rgba(240, 200, 0, 0.2)">↑ triglycerides</span> 
- Indications
	- Combination treatment with statins in hypercholesterolemia
	- Digitoxin overdose
- Adverse effects
	- Gastrointestinal: nausea, abdominal bloating and cramping